Infection control measures and surveillance of patients with ventricular assist devices;Infektionsprävention und -surveillance bei kunstherzpatienten

Anaesthesist

Volumn 56, Issue 5, 2007, Pages 429-436

  Mattner, F ^a   Chaberny, I F ^a   Mattner, L ^b   Gastmeier, P ^a   Tessmann R ^a   Struber M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Artificial heart; End stage cardiac failure; Post operative infection; Prevention; Surveillance

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; FLUCONAZOLE; GENTAMICIN; LEVOFLOXACIN; PSEUDOMONIC ACID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; ENDOCARDITIS; HEART ASSIST DEVICE; HEART FAILURE; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MORBIDITY; POSTOPERATIVE INFECTION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CLINICAL TRIALS; ENDOCARDITIS, BACTERIAL; HEART-ASSIST DEVICES; HUMANS; MONITORING, PHYSIOLOGIC; PROSTHESIS-RELATED INFECTIONS; RANDOMIZED CONTROLLED TRIALS;

EID: 34347374111     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1155-3     Document Type: Article

References (46)

1. Arusoglu L, Koerfer R, Tenderich G et al. (1999) A novel method to reduce device-related infections in patients supported with the HeartMate device. Ann Thorac Surg 68: 1875-1877
2. Bentz B, Hupcey JE, Polomano RC, Boehmer JP (2004) A retrospective study of left ventricular assist device-related infections. J Cardiovasc Manag 15: 9-16
3. Bratzler DW, Houck PM (2004) Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project. Clin Infect Dis 38: 1706-1715
4. Chaiyakunapruk N, Veenstra DL, Lipsky BA et al. (2003) Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine. Clin Infect Dis 37: 764-771
5. Chambers ST, Sanders J, Patton WN et al. (2005) Reduction of exit-site infections of tunnelled intravascular catheters among neutropenic patients by sustained-release chlorhexidine dressings: results from a prospective randomized controlled trial. J Hosp Infect 61: 53-61
6. Choi L, Choudhri AF, Pillarisetty VG et al. (1999) Development of an infection-resistant LVAD driveline: a novel approach to the prevention of device-related infections. J Heart Lung Transplant 18: 1103-1110
7. Dettenkofer M, Jonas D, Wiechmann C et al. (2002) Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection 30: 282-285
8. El-Banayosy A, Fey O, Sarnowski P et al. (2001) Midterm follow-up of patients discharged from hospital under left ventricular assistance. J Heart Lung Transplant 20: 53-58
9. El-Banayosy A, Korfer R, Arusoglu L et al. (2001) Device and patient management in a bridge-to-transplant setting. Ann Thorac Surg 71: S98-102; discussion S114-105
10. Frazier OH, Rose EA, Oz MC et al. (2001) Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantation. J Thorac Cardiovasc Surg 122: 1186-1195
11. Frazier OH, Rose EA, Oz MC et al. (2001) Multicenter clinical evaluation of the heartmate; vented electric left ventricular assist system in patients awaiting heart transplantation. J Heart Lung Transplant 20: 201-202
12. Garland JS, Alex CP, Mueller CD et al. (2001) A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 107: 1431-1436
13. Gordon RJ, Quagliarello B, Lowy FD (2006) Ventricular assist device-related infections. Lancet Infect Dis 6: 426-437
14. Gordon SM, Schmitt SK, Jacobs M et al. (2001) Nosocomial bloodstream infections in patients with implantable left ventricular assist devices. Ann Thorac Surg 72: 725-730
15. Gorler H, Haverich A (2004) Herztransplantation und Assist Devices. Herz 29: 695-701
16. Hanazaki K, Shingu K, Adachi W et al. (1999) Chlorhexidine dressing for reduction in microbial colonization of the skin with central venous catheters: a prospective randomized controlled trial. J Hosp Infect 42: 165-168
17. Harbarth S, Samore MH, Lichtenberg D, Carmeli Y (2000) Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 101: 2916-2921
18. Holman WL, Rayburn BK, McGiffin DC et al. (2003) Infection in ventricular assist devices: prevention and treatment. Ann Thorac Surg 75: S48-57
19. Holman WL, Park SJ, Long JW et al. (2004) Infection in permanent circulatory support: experience from the REMATCH trial. J Heart Lung Transplant 23: 1359-1365
20. Horstkotte D, Follath F, Gutschik E et al. (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary; the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25: 267-276
21. Icenogle T, Sandler D, Puhlman M et al. (2003) Intraperitoneal pocket for left ventricular assist device placement. J Heart Lung Transplant 22: 818-821
22. Kalya AV, Tector AJ, Crouch JD et al. (2005) Comparison of Novacor and HeartMate vented electric left ventricular assist devices in a single institution. J Heart Lung Transplant 24: 1973-1975
23. Klodell CT, Staples ED, Aranda JM Jr et al. (2006) Managing the post-left ventricular assist device patient. Congest Heart Fail 12: 41-45
24. Kreter B, Woods M (1992) Antibiotic prophylaxis for cardiothoracic operations. Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg 104: 590-599
25. Langgartner J, Linde HJ, Lehn N et al. (2004) Combined skin disinfection with chlorhexidine/propanol and aqueous povidone-iodine reduces bacterial colonisation of central venous catheters. Intensive Care Med 30: 1081-1088
26. Levy I, Katz J, Solter E et al. (2005) Chlorhexidine-impregnated dressing for prevention of colonization of central venous catheters in infants and children: a randomized controlled study. Pediatr Infect Dis J 24: 676-679
27. Lund JP, Drews T, Hetzer R, Reichart PA (2002) Oral surgical management of patients with mechanical circulatory support. Int J Oral Maxillofac Surg 31: 629-633
28. Maki DG, Narans LL, Knasinski V, Kluger DM (2000) Prospective randomized, investigator-masked trial of a novel chlorhexidine-impregnated disk (Biopatch) on central venous and arterial catheters [abstract]. Program and Abstracts of the Fourth International Decennial Conference on Nosocomial and Healthcare-Associated Infections; March 8, 2000; Atlanta, GA. Infect Control Hosp Epidemiol 21: 96
29. Minami K, El-Banayosy A, Sezai A et al. (2000) Morbidity and outcome after mechanical ventricular support using Thoratec, Novacor, and HeartMate for bridging to heart transplantation. Artif Organs 24: 421-426
30. Navia JL, McCarthy PM, Hoercher KJ et al. (2002) Do left ventricular assist device (LVAD) bridge-to-transplantation outcomes predict the results of permanent LVAD implantation? Ann Thorac Surg 74: 2051-2062; discussion 2062-2053
31. O'Grady NP, Alexander M, Dellinger EP et al. (2002) Guidelines for the prevention of intravascular catheter-related infections. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention, U.S. Pediatrics 110: e51
32. Parienti JJ, Cheyron D du, Ramakers M et al. (2004) Alcoholic povidone-iodine to prevent central venous catheter colonization: a randomized unit-crossover study. Crit Care Med 32: 708-713
33. Park SJ, Tector A, Piccioni W et al. (2005) Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129: 9-17
34. Poston RS, Husain S, Sorce D et al. (2003) LVAD bloodstream infections: therapeutic rationale for transplantation after LVAD infection. J Heart Lung Transplant 22: 914-921
35. Reedy JE, Ruzevich SA, Noedel NR et al. (1990) Nursing care of the ambulatory patient with a mechanical assist device. J Heart Transplant 9: 97-105
36. Rose EA, Gelijns AC, Moskowitz AJ et al. (2001) Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345: 1435-1443
37. Shinn JA (2005) Infection: an Achilles heel of destination left ventricular assist device therapy. Prog Cardiovasc Nurs 20: 86-87
38. Simon D, Fischer S, Grossman A et al. (2005) Left ventricular assist device-related infection: treatment and outcome. Clin Infect Dis 40: 1108-1115
39. Sinha P, Chen JM, Flannery M et al. (2000) Infections during left ventricular assist device support do not affect posttransplant outcomes. Circulation 102: III194-199
40. Skinner JL, Harris C, Aaron MF et al. (2000) Cost-benefit analysis of extended antifungal prophylaxis in ventricular assist devices. ASAIO J 46: 587-589
41. Stevenson LW, Shekar P (2005) Ventricular assist devices for durable support. Circulation 112: e111-115
42. Tablan OC, Anderson LJ, Besser R et al. (2004) Guidelines for preventing health-care - associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee. MMWR Recomm Rep 53: 1-36
43. Tietz A, Frei R, Dangel M et al. (2005) Octenidine hydrochloride for the care of central venous catheter insertion sites in severely immunocompromised patients. Infect Control Hosp Epidemiol 26: 703-707
44. Weitkemper HH, El-Banayosy A, Arusoglu L et al. (2004) Mechanical circulatory support: reality and dreams experience of a single center. J Extra Corpor Technol 36: 169-173
45. Williams MR, Oz MC (2001) Indications and patient selection for mechanical ventricular assistance. Ann Thorac Surg 71: S86-91; discussion S114-115
46. Zelenitsky SA, Ariano RE, Harding GK, Silverman RE (2002) Antibiotic pharmacodynamics in surgical prophylaxis: an association between intraoperative antibiotic concentrations and efficacy. Antimicrob Agents Chemother 46: 3026-3030